PDGFRB translocation alone appears to be a leukemogenic driver (14), explaining the usual absence of additional mutations or cytogenetic anomalies—similar to BCR::ABL1 in CML. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.